Alnylam's Patient Access Philosophy, established in 2017, was revisited in 2024 to expand its reach and ensure patients benefit from their medicines.
02
Alnylam launched a 'Patient Perspectives series' in 2024 to help employees understand the experiences of patients, caregivers, and advocates impacted by the diseases they serve.
03
In 2024, Alnylam focused on cardiovascular provider collaboration, engaging global cardiologists and other specialists to understand their needs due to two approved medicines and a robust pipeline in this area.
04
Alnylam's modular drug discovery platform utilizes a three-pronged approach: delivery of RNAi therapeutics to new tissues, enhancement of existing platform designs, and investment in human genetics to identify drug targets.
05
Alnylam was named to Newsweek’s 'America’s Most Responsible Companies 2025' for the third consecutive year, moving from #422 in 2023 to #153 in 2025.
06
In 2024, nearly 50% of Alnylam employees participated in community impact efforts, including Community Service Week, Alnylam Challengers events, and disaster-response campaigns.
07
Alnylam's Kendall campus recycled, repurposed, or donated 4,484 lbs of materials in February 2024 and recycled 688 lbs of electronic waste from its Kendall Square facility and 330 lbs from its Norton facility during Earth Day initiatives.
Insights
01
Alnylam's Patient Access Philosophy, established in 2017, was revisited in 2024 to expand its reach and ensure patients benefit from their medicines.
02
Alnylam launched a 'Patient Perspectives series' in 2024 to help employees understand the experiences of patients, caregivers, and advocates impacted by the diseases they serve.
03
In 2024, Alnylam focused on cardiovascular provider collaboration, engaging global cardiologists and other specialists to understand their needs due to two approved medicines and a robust pipeline in this area.
04
Alnylam's modular drug discovery platform utilizes a three-pronged approach: delivery of RNAi therapeutics to new tissues, enhancement of existing platform designs, and investment in human genetics to identify drug targets.
05
Alnylam was named to Newsweek’s 'America’s Most Responsible Companies 2025' for the third consecutive year, moving from #422 in 2023 to #153 in 2025.
06
In 2024, nearly 50% of Alnylam employees participated in community impact efforts, including Community Service Week, Alnylam Challengers events, and disaster-response campaigns.
07
Alnylam's Kendall campus recycled, repurposed, or donated 4,484 lbs of materials in February 2024 and recycled 688 lbs of electronic waste from its Kendall Square facility and 330 lbs from its Norton facility during Earth Day initiatives.